FDA fiscal 1986 appropriations
Executive Summary
Continuing resolution passed by Congress just before adjournment in December included $424.3 mil. for FDA, $422.8 mil. for programs and operations and $1.5 mil. for buildings and facilities. The 1986 funding level is $9.5 mil. higher than the 1985 appropriation, although it will fund 60 fewer full-time equivalent positions. Actual funding could be affected by two factors, the agency noted: a clause permitting President Reagan to reduce the appropriation by 0.6%, and the Gramm-Rudman-Hollings Deficit Reduction Act.
You may also be interested in...
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: